Neuropeptidni Y receptor Y5

Из Википедије, слободне енциклопедије
Neuropeptidni Y receptor Y5
Identifikatori
Simboli NPY5R; NPYR5
Vanjski ID OMIM602001 MGI108082 HomoloGene21241 IUPHAR: Y5 GeneCards: NPY5R Gene
Pregled RNK izražavanja
PBB GE NPY5R 207400 at tn.png
podaci
Ortolozi
Vrsta Čovek Miš
Entrez 4889 18168
Ensembl ENSG00000164129 ENSMUSG00000044014
UniProt Q15761 Q543U8
RefSeq (mRNA) NM_006174 NM_016708
RefSeq (protein) NP_006165 NP_057917
Lokacija (UCSC) Chr 4:
164.48 - 164.49 Mb
Chr 8:
69.61 - 69.62 Mb
PubMed pretraga [1] [2]

Neuropeptidni Y receptor tip 5 je protein koji je kod ljudi kodiran NPY5R genom.[1][2][3]

Selektivni ligandi[уреди]

Agonisti[уреди]

Antagonisti[уреди]

Vidi još[уреди]

Literatura[уреди]

  1. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL (1996). „A receptor subtype involved in neuropeptide-Y-induced food intake”. Nature. 382 (6587): 168—71. doi:10.1038/382168a0. PMID 8700207. 
  2. Lutz CM, Richards JE, Scott KL, Sinha S, Yang-Feng TL, Frankel WN, Thompson DA (1998). „Neuropeptide Y receptor genes mapped in human and mouse: receptors with high affinity for pancreatic polypeptide are not clustered with receptors specific for neuropeptide Y and peptide YY”. Genomics. 46 (2): 287—90. doi:10.1006/geno.1997.5024. PMID 9417917. 
  3. „Entrez Gene: NPY5R neuropeptide Y receptor Y5”. 
  4. Kakui N, Tanaka J, Tabata Y, Asai K, Masuda N, Miyara T, Nakatani Y, Ohsawa F, Nishikawa N, Sugai M, Suzuki M, Aoki K, Kitaguchi H (2006). „Pharmacological characterization and feeding-suppressive property of FMS586 [3-(5,6,7,8-tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl-ethyl)-urea hydrochloride], a novel, selective, and orally active antagonist for neuropeptide Y Y5 receptor”. The Journal of Pharmacology and Experimental Therapeutics. 317 (2): 562—70. doi:10.1124/jpet.105.099705. PMID 16436501. 
  5. Walker MW, Wolinsky TD, Jubian V, Chandrasena G, Zhong H, Huang X, Miller S, Hegde LG, Marsteller DA, Marzabadi MR, Papp M, Overstreet DH, Gerald CP, Craig DA (2009). „The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 (N-([trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl)-methanesulfonamide) exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity”. The Journal of Pharmacology and Experimental Therapeutics. 328 (3): 900—11. doi:10.1124/jpet.108.144634. PMID 19098165. 
  6. MacNeil DJ (2007). „NPY Y1 and Y5 receptor selective antagonists as anti-obesity drugs”. Current Topics in Medicinal Chemistry. 7 (17): 1721—33. doi:10.2174/156802607782341028. PMID 17979781. 
  7. Islam I, Dhanoa D, Finn J, Du P, Walker MW, Salon JA, Zhang J, Gluchowski C (2002). „Discovery of potent and selective small molecule NPY Y5 receptor antagonists”. Bioorganic & Medicinal Chemistry Letters. 12 (13): 1767—9. doi:10.1016/S0960-894X(02)00287-1. PMID 12067557. 

Dodatna literatura[уреди]